Dr. Gandara Spotlights the Giants of Cancer Care

David R. Gandara, MD
Published: Friday, Jul 26, 2013

David R. Gandara, MD, Professor of Medicine, Division of Hematology and Oncology, Director, Thoracic Oncology Program, Associate Director, Clinical Research, UC Davis Cancer Center, discusses the 2013 recipient of the Giants of Cancer Care award in the field of thoracic oncology: Thomas J. Lynch, Jr., MD.

Lynch is well known across the United States as a leader in the field of thoracic oncology, Gandara notes. He is best known for leading the team that pioneered molecular testing for EGFR mutations in lung cancer. Lynch currently serves as the director of the Yale Cancer Center, where he is building an extraordinary lung cancer research team, Gandara adds.

The 2013 Giants of Cancer Care was conducted at the Hyatt Regency in Huntington Beach, California.

For more information on the Giants of Cancer Care, visit giants.onclive.com

David R. Gandara, MD, Professor of Medicine, Division of Hematology and Oncology, Director, Thoracic Oncology Program, Associate Director, Clinical Research, UC Davis Cancer Center, discusses the 2013 recipient of the Giants of Cancer Care award in the field of thoracic oncology: Thomas J. Lynch, Jr., MD.

Lynch is well known across the United States as a leader in the field of thoracic oncology, Gandara notes. He is best known for leading the team that pioneered molecular testing for EGFR mutations in lung cancer. Lynch currently serves as the director of the Yale Cancer Center, where he is building an extraordinary lung cancer research team, Gandara adds.

The 2013 Giants of Cancer Care was conducted at the Hyatt Regency in Huntington Beach, California.

For more information on the Giants of Cancer Care, visit giants.onclive.com




View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: 18th Annual International Lung Cancer Congress®Oct 31, 20181.5
Clinical Interchange™: Translating Research to Inform Changing Paradigms: Assessment of Emerging Immuno-Oncology Strategies and Combinations across Lung, Head and Neck, and Bladder CancersOct 31, 20182.0
Publication Bottom Border
Border Publication
x